Melanoma Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Melanoma stocks.

Melanoma Stocks Recent News

Date Stock Title
Apr 26 BMY Investor Sentiment Improves Slightly, But Dow Tumbles Over 350 Points
Apr 26 BMY Q1 2024 Bristol-Myers Squibb Co Earnings Call
Apr 26 BMY Bristol-Myers Q1 Loss Narrower Than Expected, Sales Beat
Apr 25 BMY Bristol Myers Squibb stock tumbles on cost-cutting initiative
Apr 25 BMY Bristol-Myers Squibb Stock: Gloomy Q1 Earnings Trigger Justified Sell-Off
Apr 25 BMY Biotech Stock Roundup: BIIB, BMY's Q1 Earnings, INCY's Acquisition & Updates from VRTX
Apr 25 BMY Bristol Myers Squibb Swings To Quarterly Loss, After String Of Multi-Billion Acquisitions
Apr 25 BMY Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Apr 25 BMY Bristol-Myer Squibb Company (BMY) Q1 2024 Earnings Call Transcript
Apr 25 BMY Update: Bristol-Myers Squibb Swings to Q1 Non-GAAP Loss, Revenue Rises; Provides 2024 Guidance -- Shares Fall
Apr 25 BMY Bristol Myers (BMY) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Revised)
Apr 25 BMY Why Bristol Myers Squibb Stock Is Sinking Today
Apr 25 BMY Bristol-Myers (BMY) Q1 Loss Narrower Than Expected, Sales Beat
Apr 25 BMY Heard on the Street: Bristol-Myers Goes From Big Pharma to Little Pharma
Apr 25 BMY Bristol Myers Squibb (BMY) Q1 2024 Earnings Call Transcript
Apr 25 BMY Bristol Myers Cuts Full-Year Earnings Forecast, Launches Cost Cuts
Apr 25 BMY Is Bristol Myers Squibb Stock a Millionaire Maker?
Apr 25 BMY AstraZeneca Flirts With A Breakout After Cancer Drug Sales Shine; Sanofi, Bristol Stocks Diverge
Apr 25 BMY Bristol-Myers to cut 2,200 jobs as part of $1.5B cost savings plan
Apr 25 BMY Bristol-Myers Squibb to Cut 2,200 Jobs as Part of $1.5 Billion Cost-Cutting Effort
Melanoma

Melanoma, also known as malignant melanoma, is a type of cancer that develops from the pigment-containing cells known as melanocytes. Melanomas typically occur in the skin, but may rarely occur in the mouth, intestines, or eye. In women, they most commonly occur on the legs, while in men they are most common on the back. Sometimes they develop from a mole with changes such as an increase in size, irregular edges, change in color, itchiness, or skin breakdown.The primary cause of melanoma is ultraviolet light (UV) exposure in those with low levels of skin pigment. The UV light may be from either the sun or from other sources, such as tanning devices. About 25% develop from moles. Those with many moles, a history of affected family members, and who have poor immune function are at greater risk. A number of rare genetic defects such as xeroderma pigmentosum also increase risk. Diagnosis is by biopsy and analysis of any skin lesion that has signs of being potentially cancerous.Using sunscreen and avoiding UV light may prevent melanoma. Treatment is typically removal by surgery. In those with slightly larger cancers, nearby lymph nodes may be tested for spread. Most people are cured if spread has not occurred. For those in whom melanoma has spread, immunotherapy, biologic therapy, radiation therapy, or chemotherapy may improve survival. With treatment the five-year survival rates in the United States is 98% among those with localized disease and 17% among those in whom spread has occurred. The likelihood that it will come back or spread depends how thick the melanoma is, how fast the cells are dividing, and whether or not the overlying skin has broken down.Melanoma is the most dangerous type of skin cancer. Globally, in 2012, it newly occurred in 232,000 people. In 2015 there were 3.1 million with active disease which resulted in 59,800 deaths. Australia and New Zealand have the highest rates of melanoma in the world. There are also high rates in Northern Europe and North America, while it is less common in Asia, Africa, and Latin America. Melanoma is more common in men than women. Melanoma has become more common since the 1960s in areas which are mostly populated with white people.

Browse All Tags